Article Details

Nabriva Therapeutics (NASDAQ:NBRV) Upgraded at Zacks Investment Research

Retrieved on: 2021-02-04 08:09:33

Tags for this article:

Click the tags to see associated articles and topics

Nabriva Therapeutics (NASDAQ:NBRV) Upgraded at Zacks Investment Research. View article details on hiswai:

Excerpt

WINTON GROUP Ltd now owns 633,831 shares of the biotechnology company's stock valued at $338,000 after purchasing an additional 266,166 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo